Open Tender for Glibenclamide tab 2 point 5 mg,Diltiazem Tab 60 mg,Glyceryl Trinitrate Sublingual Tab zero point 5 in SRINAGAR, JAMMU & KASHMIR
Bid Publish Date
09-Dec-2024, 12:07 pm
Bid End Date
30-Dec-2024, 1:00 pm
Location
Progress
Quantity
54900
Category
Glibenclamide tab 2 point 5 mg
Bid Type
Two Packet Bid
Categories
9
Directorate Of Health Services Kashmir announces a tender for Glibenclamide tab 2 point 5 mg, Diltiazem Tab 60 mg, Glyceryl Trinitrate Sublingual Tab zero point 5 Mg, Isosorbide 5 Mononitrate tab 10 Mg, Isosorbide Dinitrate Tab 5 mg, Amiodrone Tab 100 mg, Hydrochlorothiazid tab 12. 5 mg, Methyldopa Tablet 250 Mg, Enalapril Tablet 2. 5 Mg, Captopril Tab 25 mg, Lisinopril Tab 5 mg, Telmisartan Tab 40mg, Furosemide Tab 40mg, Spironolactone Tab 25mg, Clofibrate Tab 500 mg, Deriphyllin Tab SR, Fenofibrate 40mg, Indapamide 1. 5mg, Chlorthalidone Tab 12. 5mg, Budesonide Inhalation MDI DPI 100 mg per dose, Budesonide Respirator solution foe use in nubilizer 0 point 5 mg per ml, Budesonide formoterol inhalation MDI DPI 100 mg 6 mg, Iprotropium inhalation MDI DPI, Formoterol Inhaled Bronchodilator, Salmeterol Inhaled Bronchodilator, Tiotropium Inhalation MDI 9mcg per dose, Monteleukast Tab 10 mg, Monteleukast Syrup in SRINAGAR, JAMMU & KASHMIR. Quantity: 54900. Submission Deadline: 30-12-2024 13: 00: 00. Last date to apply is approaching fast!
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Glibenclamide tab 2 point 5 mg , Diltiazem Tab 60 mg , Glyceryl Trinitrate Sublingual Tab zero point 5 Mg , Isosorbide 5 Mononitrate tab 10 Mg , Isosorbide Dinitrate Tab 5 mg , Amiodrone Tab 100 mg , Hydrochlorothiazid tab 12.5 mg , Methyldopa Tablet 250 Mg , Enalapril Tablet 2.5 Mg , Captopril Tab 25 mg , Lisinopril Tab 5 mg , Telmisartan Tab 40mg , Furosemide Tab 40mg , Spironolactone Tab 25mg , Clofibrate Tab 500 mg , Deriphyllin Tab SR , Fenofibrate 40mg , Indapamide 1.5mg , Chlorthalidone Tab 12.5mg , Budesonide Inhalation MDI DPI 100 mg per dose , Budesonide Respirator solution foe use in nubilizer 0 point 5 mg per ml , Budesonide formoterol inhalation MDI DPI 100 mg 6 mg , Iprotropium inhalation MDI DPI , Formoterol Inhaled Bronchodilator , Salmeterol Inhaled Bronchodilator , Tiotropium Inhalation MDI 9mcg per dose , Monteleukast Tab 10 mg , Monteleukast Syrup
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-7218763.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
28 Items Sign in to view GEM price trends Sign in for GEM prices
Glibenclamide tab 2 point 5 mg
Glibenclamide tab 2 point 5 mg
Diltiazem Tab 60 mg
Diltiazem Tab 60 mg
Glyceryl Trinitrate Sublingual Tab zero point 5 Mg
Glyceryl Trinitrate Sublingual Tab zero point 5 Mg
Isosorbide 5 Mononitrate tab 10 Mg
Isosorbide 5 Mononitrate tab 10 Mg
Isosorbide Dinitrate Tab 5 mg
Isosorbide Dinitrate Tab 5 mg
Amiodrone Tab 100 mg
Amiodrone Tab 100 mg
Hydrochlorothiazid tab 12.5 mg
Hydrochlorothiazid tab 12.5 mg
Methyldopa Tablet 250 Mg
Methyldopa Tablet 250 Mg
Enalapril Tablet 2.5 Mg
Enalapril Tablet 2.5 Mg
Captopril Tab 25 mg
Captopril Tab 25 mg
Lisinopril Tab 5 mg
Lisinopril Tab 5 mg
Telmisartan Tab 40mg
Telmisartan Tab 40mg
Furosemide Tab 40mg
Furosemide Tab 40mg
Spironolactone Tab 25mg
Spironolactone Tab 25mg
Clofibrate Tab 500 mg
Clofibrate Tab 500 mg
Deriphyllin Tab SR
Deriphyllin Tab SR
Fenofibrate 40mg
Fenofibrate 40mg
Indapamide 1.5mg
Indapamide 1.5mg
Chlorthalidone Tab 12.5mg
Chlorthalidone Tab 12.5mg
Budesonide Inhalation MDI DPI 100 mg per dose
Budesonide Inhalation MDI DPI 100 mg per dose
Budesonide Respirator solution foe use in nubilizer 0 point 5 mg per ml
Budesonide Respirator solution foe use in nubilizer 0 point 5 mg per ml
Budesonide formoterol inhalation MDI DPI 100 mg 6 mg
Budesonide formoterol inhalation MDI DPI 100 mg 6 mg
Iprotropium inhalation MDI DPI
Iprotropium inhalation MDI DPI
Formoterol Inhaled Bronchodilator
Formoterol Inhaled Bronchodilator
Salmeterol Inhaled Bronchodilator
Salmeterol Inhaled Bronchodilator
Tiotropium Inhalation MDI 9mcg per dose
Tiotropium Inhalation MDI 9mcg per dose
Monteleukast Tab 10 mg
Monteleukast Tab 10 mg
Monteleukast Syrup
Monteleukast Syrup
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Glibenclamide tab 2 point 5 mg | Glibenclamide tab 2 point 5 mg | 2,100 | tablets | ms-gousia | 15 | |
| 2 | Diltiazem Tab 60 mg | Diltiazem Tab 60 mg | 2,100 | tablets | ms-gousia | 15 | |
| 3 | Glyceryl Trinitrate Sublingual Tab zero point 5 Mg | Glyceryl Trinitrate Sublingual Tab zero point 5 Mg | 2,000 | tablets | ms-gousia | 15 | |
| 4 | Isosorbide 5 Mononitrate tab 10 Mg | Isosorbide 5 Mononitrate tab 10 Mg | 2,000 | tablets | ms-gousia | 15 | |
| 5 | Isosorbide Dinitrate Tab 5 mg | Isosorbide Dinitrate Tab 5 mg | 2,000 | tablets | ms-gousia | 15 | |
| 6 | Amiodrone Tab 100 mg | Amiodrone Tab 100 mg | 2,000 | tablets | ms-gousia | 15 | |
| 7 | Hydrochlorothiazid tab 12.5 mg | Hydrochlorothiazid tab 12.5 mg | 2,100 | tablets | ms-gousia | 15 | |
| 8 | Methyldopa Tablet 250 Mg | Methyldopa Tablet 250 Mg | 2,000 | tablets | ms-gousia | 15 | |
| 9 | Enalapril Tablet 2.5 Mg | Enalapril Tablet 2.5 Mg | 2,000 | tablets | ms-gousia | 15 | |
| 10 | Captopril Tab 25 mg | Captopril Tab 25 mg | 2,000 | tablets | ms-gousia | 15 | |
| 11 | Lisinopril Tab 5 mg | Lisinopril Tab 5 mg | 3,000 | tablets | ms-gousia | 15 | |
| 12 | Telmisartan Tab 40mg | Telmisartan Tab 40mg | 3,000 | tablets | ms-gousia | 15 | |
| 13 | Furosemide Tab 40mg | Furosemide Tab 40mg | 3,000 | tablets | ms-gousia | 15 | |
| 14 | Spironolactone Tab 25mg | Spironolactone Tab 25mg | 2,100 | tablets | ms-gousia | 15 | |
| 15 | Clofibrate Tab 500 mg | Clofibrate Tab 500 mg | 2,000 | tablets | ms-gousia | 15 | |
| 16 | Deriphyllin Tab SR | Deriphyllin Tab SR | 2,000 | tablets | ms-gousia | 15 | |
| 17 | Fenofibrate 40mg | Fenofibrate 40mg | 2,000 | tablets | ms-gousia | 15 | |
| 18 | Indapamide 1.5mg | Indapamide 1.5mg | 2,100 | tablets | ms-gousia | 15 | |
| 19 | Chlorthalidone Tab 12.5mg | Chlorthalidone Tab 12.5mg | 2,000 | tablets | ms-gousia | 15 | |
| 20 | Budesonide Inhalation MDI DPI 100 mg per dose | Budesonide Inhalation MDI DPI 100 mg per dose | 1,500 | no | ms-gousia | 15 | |
| 21 | Budesonide Respirator solution foe use in nubilizer 0 point 5 mg per ml | Budesonide Respirator solution foe use in nubilizer 0 point 5 mg per ml | 1,500 | no | ms-gousia | 15 | |
| 22 | Budesonide formoterol inhalation MDI DPI 100 mg 6 mg | Budesonide formoterol inhalation MDI DPI 100 mg 6 mg | 1,500 | no | ms-gousia | 15 | |
| 23 | Iprotropium inhalation MDI DPI | Iprotropium inhalation MDI DPI | 1,500 | no | ms-gousia | 15 | |
| 24 | Formoterol Inhaled Bronchodilator | Formoterol Inhaled Bronchodilator | 1,600 | no | ms-gousia | 15 | |
| 25 | Salmeterol Inhaled Bronchodilator | Salmeterol Inhaled Bronchodilator | 1,500 | no | ms-gousia | 15 | |
| 26 | Tiotropium Inhalation MDI 9mcg per dose | Tiotropium Inhalation MDI 9mcg per dose | 1,500 | no | ms-gousia | 15 | |
| 27 | Monteleukast Tab 10 mg | Monteleukast Tab 10 mg | 300 | tablets | ms-gousia | 15 | |
| 28 | Monteleukast Syrup | Monteleukast Syrup | 2,500 | syrups | ms-gousia | 15 |
🤖 AI-Powered Bidder Prediction
Discover companies most likely to bid on this tender
Required Documents
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Corrigendum Updates
1 Update Update
Extended Deadline
14-Jan-2025, 9:00 am
Opening Date
14-Jan-2025, 9:30 am
Frequently Asked Questions
Key insights about JAMMU AND KASHMIR tender market
What are the eligibility requirements for bidders?
The eligibility requirements include being a registered entity and demonstrating a minimum of three years of previous experience supplying similar pharmaceutical products to government organizations or PSUs. Bidders must also comply with all documentation requirements outlined in the tender.
What documents are required to submit a bid?
Bidders must provide comprehensive documentation, including:
- Experience Criteria documentation
- Past Performance documentation
- Bidder Turnover certificates
- OEM Authorization certificate
- Compliance with BoQ specifications and supporting documents
Is there an exemption for small enterprises regarding experience and turnover?
Yes, there are provisions allowing some exemptions for Micro, Small, and Medium Enterprises (MSEs). However, these should be justified and supported with appropriate documentation.
What are the technical specifications for the pharmaceutical products?
All products must comply with the specified BoQ specifications. Detailed specifications can be found in the documents linked within the tender notice.
Are there any compliance requirements for the pharmaceutical products?
Yes, compliance with defined quality standards and submission of necessary certificates is mandatory to ensure safety and efficacy in the products supplied.
What is the Earnest Money Deposit (EMD) for this tender?
At present, there is no requirement for an EMD for this tender, ensuring easier participation for potential bidders.
What performance security requirements should be considered?
There is no performance security bond required for this tender, simplifying the bidding process for participants.
What payment terms apply for this tender?
Payment terms will be defined based on the negotiations and agreements post-bid acceptance, in line with governmental procurement policies.
What is the process for bid submission?
Bids must be submitted electronically via the designated online platform as per the detailed instructions outlined in the tender document.
How soon will bidders be notified of the results?
Bidders will be notified promptly following the conclusion of the evaluation process; timelines are usually specified in the documentation.
Are there benefits available for startups?
Yes, startups may have provisions under this tender that facilitate participation by easing certain requirements, but specific conditions apply that must be verified in the documentation.
What measures are in place to encourage 'Make in India' compliance?
Certain preferences will be granted to bids that meet the Make in India standards, particularly for local suppliers, as outlined in the tender document.
How does the evaluation and selection process work?
Bids will be evaluated based on technical specification compliance, financial standing, and value-based evaluation parameters. Both technical and financial aspects will be scrutinized to determine the winning bids.
What should bidders know about local content and procurement per the regulations?
Local content must be a minimum of 50% for qualifying as a Class 1 local supplier under the Make in India standards, ensuring contributions to the local economy and sustainability efforts.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 4
GeM-Bidding-7218763.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS